PTCT

PTC Therapeutics, Inc.NASDAQHealthcare

$67.77-1.43%ClosedMarket Cap: $5.61B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-30	Jefferies	—	Hold	—
2026-02-23	Morgan Stanley	—	Overweight	—
2026-02-20	Wells Fargo	—	Overweight	—
2026-02-20	RBC Capital	—	Sector Perform	—
2026-02-20	B of A Securities	—	Buy	—
2026-01-28	Barclays	—	Overweight	—
2025-12-01	RBC Capital	—	Sector Perform	—
2025-11-06	Barclays	—	Equal Weight	—
2025-11-05	RBC Capital	—	Outperform	—
2025-11-05	Citigroup	—	Neutral	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.93	$1.10B	6
Sun Dec 31	$0.57	$1.27B	6
Mon Dec 31	$2.98	$1.43B	4
Tue Dec 31	$3.99	$1.56B	2